Logo for Humanigen Inc

Humanigen Investor Relations Material

Latest events

Logo for Humanigen

Q4 2022

30 Mar, 2023
Logo for Humanigen

Q4 2021

1 Mar, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Humanigen Inc

Access all reports
Humanigen, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a portfolio of anti-inflammatory immunology and immuno-oncology monoclonal antibodies in the United States.